These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36357250)

  • 1. Association between transforming growth factors-β and matrix metalloproteinases in the aqueous humor and plasma in myopic patients.
    Yue Y; Che D; Hsiao YW; Zhou J; Zhao K
    J Fr Ophtalmol; 2022 Dec; 45(10):1177-1183. PubMed ID: 36357250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human aqueous humor levels of transforming growth factor-β2: Association with matrix metalloproteinases/tissue inhibitors of matrix metalloproteinases.
    Jia Y; Yue Y; Hu DN; Chen JL; Zhou JB
    Biomed Rep; 2017 Dec; 7(6):573-578. PubMed ID: 29188062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher TGF-β1, TGF-β2, MMP-2, and TIMP-1 Levels in the Aqueous Humor of Patients with Acute Primary Angle Closure.
    Chen Y; Yan H; Li G; Zhang Y
    Ophthalmic Res; 2021; 64(1):62-67. PubMed ID: 32259818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations Between MMPs and TIMPs Levels in Aqueous Humor from High Myopia and Cataract Patients.
    Jia Y; Hu DN; Sun J; Zhou J
    Curr Eye Res; 2017 Apr; 42(4):600-603. PubMed ID: 28402202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between Axial Length and Levels of TGF-
    Hsiao Y; Cao Y; Yue Y; Zhou J
    Biomed Res Int; 2021; 2021():8863637. PubMed ID: 33728344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMP-2, MMP-3, TIMP-1, TIMP-2, and TIMP-3 protein levels in human aqueous humor: relationship with axial length.
    Jia Y; Hu DN; Zhu D; Zhang L; Gu P; Fan X; Zhou J
    Invest Ophthalmol Vis Sci; 2014 May; 55(6):3922-8. PubMed ID: 24876280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor beta1, matrix-metalloproteinase-2 and its tissue inhibitor in patients with pseudoexfoliation glaucoma/syndrome.
    Djordjević-Jocić J; Zlatanović G; Veselinović D; Jovanović P; Djordjević V; Zvezdanović L; Stanković-Babić G; Vujanović M; Cekić S; Zenkel M; Schlotzer-Schrehardt U
    Vojnosanit Pregl; 2012 Mar; 69(3):231-6. PubMed ID: 22624408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between MMP/TIMP Levels in the Aqueous Humor and Plasma with Axial Lengths in Myopia Patients.
    Yue Y; Hsiao YW; Zhou JB
    Biomed Res Int; 2020; 2020():2961742. PubMed ID: 32596291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of extracellular matrix homeostasis of normal cartilage by a TGFbeta autocrine pathway. Validation of flow cytometry as a tool to study chondrocyte metabolism in vitro.
    Wang L; Almqvist KF; Veys EM; Verbruggen G
    Osteoarthritis Cartilage; 2002 Mar; 10(3):188-98. PubMed ID: 11869079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-β2 levels in the aqueous humor are elevated in the second eye of high myopia within two weeks after sequential cataract surgery.
    Yan W; Zhang Y; Cao J; Yan H
    Sci Rep; 2022 Oct; 12(1):17974. PubMed ID: 36289352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2, and transforming growth factor beta 1 in the aqueous humor and serum of patients with pseudoexfoliation syndrome.
    Kara S; Yildirim N; Ozer A; Colak O; Sahin A
    Clin Ophthalmol; 2014; 8():305-9. PubMed ID: 24511224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular TGF-
    Saucedo L; Pfister IB; Zandi S; Gerhardt C; Garweg JG
    Mediators Inflamm; 2021; 2021():9811361. PubMed ID: 34257518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma transforming growth factor beta1, metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 in acute viral hepatitis type B.
    Flisiak R; Jaroszewicz J; Lapiński TW; Flisiak I; Rogalska M; Prokopowicz D
    Regul Pept; 2005 Nov; 131(1-3):54-8. PubMed ID: 16081167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of TGF-β2, MMP-2, and TIMP-2 levels in the vitreous of patients with high myopia.
    Zhuang H; Zhang R; Shu Q; Jiang R; Chang Q; Huang X; Jiang C; Xu G
    Graefes Arch Clin Exp Ophthalmol; 2014 Nov; 252(11):1763-7. PubMed ID: 25112847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lamivudine treatment on plasma levels of transforming growth factor beta1, tissue inhibitor of metalloproteinases-1 and metalloproteinase-1 in patients with chronic hepatitis B.
    Flisiak R; Al-Kadasi H; Jaroszewicz J; Prokopowicz D; Flisiak I
    World J Gastroenterol; 2004 Sep; 10(18):2661-5. PubMed ID: 15309715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human aqueous humor levels of TGF- β2: relationship with axial length.
    Jia Y; Hu DN; Zhou J
    Biomed Res Int; 2014; 2014():258591. PubMed ID: 24967344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of matrix metalloproteinases (MMPs) and their tissue inhibitors in human myometrial smooth muscle cells by TGF-beta1.
    Ma C; Chegini N
    Mol Hum Reprod; 1999 Oct; 5(10):950-4. PubMed ID: 10508223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparative role of activator protein 1 and Smad factors in the regulation of Timp-1 and MMP-1 gene expression by transforming growth factor-beta 1.
    Hall MC; Young DA; Waters JG; Rowan AD; Chantry A; Edwards DR; Clark IM
    J Biol Chem; 2003 Mar; 278(12):10304-13. PubMed ID: 12525489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-β1 modulates the homeostasis between MMPs and MMP inhibitors through p38 MAPK and ERK1/2 in highly invasive breast cancer cells.
    Gomes LR; Terra LF; Wailemann RA; Labriola L; Sogayar MC
    BMC Cancer; 2012 Jan; 12():26. PubMed ID: 22260435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pegylated interferon alpha 2b plus ribavirin treatment on plasma transforming growth factor-beta1, metalloproteinase-1, and tissue metalloproteinase inhibitor-1 in patients with chronic hepatitis C.
    Flisiak R; Jaroszewicz J; Lapinski TW; Flisiak I; Prokopowiczi D
    World J Gastroenterol; 2005 Nov; 11(43):6833-8. PubMed ID: 16425392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.